The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: nevirapine     Quarter: 2016Q3

Total Drug/Injury Combinations: 163     Number of Pages: 9

DRUGNAME PT EventCount
NEVIRAPINE. Foetal exposure during pregnancy 58 view events
NEVIRAPINE. Exposure during pregnancy 48 view events
NEVIRAPINE. Exposure during breast feeding 28 view events
NEVIRAPINE. Anaemia 25 view events
NEVIRAPINE. Oral disorder 16 view events
NEVIRAPINE. Corneal lesion 14 view events
NEVIRAPINE. Drug resistance 13 view events
NEVIRAPINE. Genital lesion 12 view events
NEVIRAPINE. Stevens-Johnson syndrome 11 view events
NEVIRAPINE. Toxic epidermal necrolysis 11 view events
NEVIRAPINE. Foetal distress syndrome 10 view events
NEVIRAPINE. Low birth weight baby 10 view events
NEVIRAPINE. Premature delivery 10 view events
NEVIRAPINE. Premature baby 9 view events
NEVIRAPINE. Lipodystrophy acquired 7 view events
NEVIRAPINE. Stillbirth 7 view events
NEVIRAPINE. Death 6 view events
NEVIRAPINE. Gamma-glutamyltransferase increased 6 view events
NEVIRAPINE. Neuropathy peripheral 6 view events
NEVIRAPINE. Postpartum sepsis 6 view events

Total Drug/Injury Combinations: 163     Number of Pages: 9

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)